Amgen is running a number of studies of its obesity drug, MariTide.

Analysts expect the company to post earnings of $4.76, representing a 10.4% drop from the corresponding period of the ...

In its upcoming report, Amgen (AMGN) is predicted by Wall Street analysts to post quarterly earnings of $4.74 per share, ...

Amgen (NASDAQ:AMGN) reported fourth-quarter earnings that exceeded analyst expectations, with revenue climbing 9% to $9.9 ...

Amgen Inc. reports fourth-quarter earnings today after the bell, putting the spotlight on how the $185.6 billion biotechnology giant plans to navigate a year marked by significant biosimilar ...

Feb 3 (Reuters) - Amgen on Tuesday reported fourth-quarter financial results that came in ahead of Wall Street expectations, driven by a 7% increase in drug sales and a lower tax rate. The ...

RFK Jr. says TrumpRX will launch "probably in the next 10 days." What we know about how buying medicine, getting discounts on ...